The epidemiology of Her-2/neu and P53 in breast cancer

被引：5

作者：

Bernstein, JL ^{[1
]}

López-Carrillo, L ^{[1
]}

Wang, L ^{[1
]}

机构：

[1] CUNY Mt Sinai Sch Med, Dept Community Med, New York, NY 10029 USA

来源：

SALUD PUBLICA DE MEXICO | 1999年 / 41卷

关键词：

breast neoplasms; genes; risk factors; biological markers; racial stocks;

D O I：

10.1590/S0036-36341999000800008

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Breast cancer is an etiologically heterogeneous disease with marked geographical variations. Joint consideration of the relationship between specific molecular alterations and known or suspected epidemiologic risk factors for this disease should help distinguish subgroups of women that are at elevated risk of developing breast cancer. In this article, we present a comprehensive literature review of the etiologic and prognostic roles of Her-2/neu and P53 among women. In addition,we discuss the advantages and limitations of using biomarkers in epidemiological studies. We conclude that more research is needed to understand the complex relationships between genetic alterations and etiologic risk factors for breast cancer.

引用

下载

页码：S114 / S123

页数：10

共 50 条

[11] Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
Brodowicz, T
Kandioler, D
Tomek, S
Ludwig, C
Rudas, M
Kunstfeld, R
Koestler, W
Hejna, M
Budinsky, A
Krainer, M
Wiltschke, C
Zielinski, CC
BRITISH JOURNAL OF CANCER, 2001, 85 (11) : 1764 - 1770
[12] Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
T Brodowicz
D Kandioler
S Tomek
C Ludwig
M Rudas
R Kunstfeld
W Koestler
M Hejna
A Budinsky
C Wiltschke
C C Zielinski
British Journal of Cancer, 2001, 85 : 1764 - 1770
[13] Her-2/neu and breast cancer
Kaptain, S
Tan, LK
Chen, BY
DIAGNOSTIC MOLECULAR PATHOLOGY, 2001, 10 (03) : 139 - 152
[14] Detection of genetic instability at HER-2/neu and p53 loci in breast cancer cells sing Comet–FISH
Tirukalikundram S Kumaravel
Robert G Bristow
Breast Cancer Research and Treatment, 2005, 91 : 89 - 94
[15] OVEREXPRESSION OF P53 AND HER-2/NEU PROTEINS AS PROGNOSTIC MARKERS IN EARLY-STAGE BREAST-CANCER
MARKS, JR
HUMPHREY, PA
WU, K
BERRY, D
BANDARENKO, N
KERNS, BJM
IGLEHART, JD
ANNALS OF SURGERY, 1994, 219 (04) : 332 - 341
[16] Prognostic values of p53 and HER-2/neu coexpression in invasive bladder cancer in Taiwan
Tsai, YS
Tzai, TS
Chow, NH
Yang, WH
Tong, YC
Lin, JSN
Chang, CC
Cheng, HL
Lin, YM
UROLOGIA INTERNATIONALIS, 2003, 71 (03) : 262 - 270
[17] Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer
Nijman, HW
Kenemans, P
Poort-Keesom, RJJ
Verstraeten, RA
Mensdorff-Pouilly, S
Verheijen, RHM
Melief, CJM
Hilgers, J
Meijer, CJLM
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1999, 83 (02): : 201 - 206
[18] Significance of p53, bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer
Al-Moundhri, M
Nirmala, V
Al-Mawaly, K
Ganguly, S
Burney, I
Rizvi, A
Grant, C
PATHOLOGY & ONCOLOGY RESEARCH, 2003, 9 (04) : 226 - 231
[19] Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer
Jongen, Vincent H. W. M.
Briet, Justine M.
de Jong, Renske A.
Joppe, Erna
ten Hoor, Klaske A.
Boezen, H. M.
Evans, Dean B.
Hollema, Harry
van der Zee, Ate G. J.
Nijman, Hans W.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (04) : 670 - 676
[20] Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice
Nanni, P
Nicoletti, G
De Giovanni, C
Croci, S
Astolfi, A
Landuzzi, L
Di Carlo, E
Iezzi, M
Musiani, P
Lollini, PL
CANCER RESEARCH, 2003, 63 (11) : 2728 - 2732

← 1 2 3 4 5 →